首都医科大学附属北京中医医院呼吸科 北京 100010
李雪,女,副主任医师
# 郭亚丽,女,博士,主治医师,E-mail:275977208@qq.com
纸质出版日期:2023-07-30,
收稿日期:2023-04-03,
移动端阅览
李雪, 王玉光, 周继朴, 等. 间质性肺疾病合并新型冠状病毒感染中医特征分析[J]. 现代中医临床, 2023,30(4):21-27.
LI Xue, WANG Yuguang, ZHOU Jipu, et al. TCM pattern analysis of interstitial lung disease with COVID-19[J]. Modern Chinese Clinical Medicine, 2023,30(4):21-27.
李雪, 王玉光, 周继朴, 等. 间质性肺疾病合并新型冠状病毒感染中医特征分析[J]. 现代中医临床, 2023,30(4):21-27. DOI: 10.3969/j.issn.2095-6606.2023.04.005.
LI Xue, WANG Yuguang, ZHOU Jipu, et al. TCM pattern analysis of interstitial lung disease with COVID-19[J]. Modern Chinese Clinical Medicine, 2023,30(4):21-27. DOI: 10.3969/j.issn.2095-6606.2023.04.005.
目的
2
分析间质性肺疾病(ILD)合并新型冠状病毒感染(简称“新冠感染”)患者的中医症状、证候分布特点,并探究其病因病机。
方法
2
采用横断面调查研究,选取69例2022年12月—2023年1月在我院门诊和病房诊断为新冠感染的ILD患者,收集门诊首诊或入院第一天的中医四诊信息、一般情况及西医临床资料。
结果
2
69例患者首发症状以肺卫症状多见,同时兼有脾系症状。69例患者共涉及23种症状。与轻、中型患者相比,重型、危重型患者中喘、胸闷、排便不爽、畏寒、恶风和痰中带血的比例较高(
P
<
0.05);而头痛的比例较低(
P
<
0.05)。69例患者中,舌质共3种,舌苔和脉象分别为6种。与轻型及中型患者相比,重型及危重型患者中燥苔和细脉比例较高(
P
<
0.05)。69例患者中有50例(72.5%)为虚实夹杂证,19例(27.5%)为实证。结合脏腑辨证,证候类型共计12个。与轻型和中型患者相比,重型及危重型患者中肾气虚证、肾阴阳两虚、热入营血证和疫毒闭肺证比例较高(
P
<
0.05),寒湿郁肺证的比例较低(
P
<
0.05)。69例患者总体病位分布主要在肺和脾。与轻型和中型患者相比,重型及危重型患者中病位在肾和营血分的比例较高(
P
<
0.05)。
结论
2
新冠感染系感受疫疠之气所致,ILD患者感染新冠病毒可表现为湿毒为胜,病机涉及正虚(肺、脾、肾)和邪实(湿热邪毒)两部分,病程初起病位在肺卫,进展期以肺脾多见,重型和危重型累及肾及营血。
Objective
2
To analyze the TCM patterns of interstitial lung disease (ILD) with corona virus disease 2019
and explore its etiology and pathogenesis.
Methods
2
A cross-sectional study was conducted
in which 69 ILD patients diagnosed with COVID-19 in our hospital’s outpatient and wards from December 2022 to January 2023 were included. Their four TCM diagnostic information
general conditions and clinical data of western medicine were collected on the first visit or the day of admission.
Results
2
Among the 69 patients
the initial manifestation was predominantly lung-
wei
syndrome
accompanied by spleen syndromes. 23 symptoms were recorded from the 69 patients. Compared with the mild and moderate cases
the proportion of dyspnea
chest tightness
incomplete defecation
fear of cold
aversion of wind
blood in sputum
dry coating on the tongue and thready pulse in severe and critical patients was significantly higher (
P
<
0.05); while the proportion of headaches was significantly low (
P
<
0.05). Among the 69 patients
there were 3 types of tongue body
and 6 types of tongue coating and pulse pattern
respectively. Compared with mild and moderate patients
the proportion of dry coating on the tongue and thready pulse was higher in severe and critical patients (
P
<
0.05). Among the 69 patients
50 (72.5%) had a mixture of deficiency and excess
while 19 (27.5%) had excess patterns. From the perspective of
zang
-
fu
organ syndrome differentiation
there were a total of 12 syndrome types. Compared with the mild and moderate patients
the proportion of kidney-qi deficiency
kidney-yin and yang deficiency
heat entering
ying
-blood and pestilence blocking the lung in severe and critical patients was significantly higher (
P
<
0.05). The proportion of cold-dampness stagnation in the lung was significantly lower (
P
<
0.05). The affected area of the 69 patients is mainly located in the lung and spleen. Compared with the mild and moderate patients
the proportion of affected area in the kidney and
ying
-blood level is higher in severe and critical patients (
P
<
0.05).
Conclusion
2
COVID-19 is caused by the contraction of pestilence qi. COVID-19 in ILD patients can be manifested as the predominance of dampness toxin. The pathogenesis involves two parts: deficiency of healthy qi (in the lung
spleen
kidney) and excess of evil qi (damp heat toxin). The onset of the disease is in the lung
wei
and it common moves to the lung and spleen in the progressive stage. In severe and critical cases
the kidney and
ying
-blood may also be involved.
间质性肺疾病新型冠状病毒症状证候病因病机
ILDCOVID-19symptomsTCM patternsetiology and pathogenesis
CHATTERJEE S, BHATTACHARYA M, NAG S, et al. A detailed overview of SARS-CoV-2 omicron: its sub-variants, mutations and pathophysiology, clinical characteristics, immunological landscape, immune escape, and therapies[J/OL]. Viruses,2023,15(1):167[2023-01-25].https://doi.org/10.3390/v15010167https://doi.org/10.3390/v15010167.
VALENZULA C, WATERER G, RAGHU G. Interstitial lung disease before and after COVID-19:a double threat? [J/OL]. Eur Respir J,2021,58(6):2101956[2023-01-25].https://doi.org/10.1183/13993003.01956-2021https://doi.org/10.1183/13993003.01956-2021.
国家卫生健康委员会,国家中医药管理局.新型冠状病毒感染诊疗方案(试行第十版)[EB/OL].(2023-01-05)[2023-01-26].http://www.nhc.gov.cn/ylyjs/pqt/202301/32de5b2ff9bf4eaa88e75bdf7223a65a/files/02ec13aadff048ffae227593a6363ee8.pdfhttp://www.nhc.gov.cn/ylyjs/pqt/202301/32de5b2ff9bf4eaa88e75bdf7223a65a/files/02ec13aadff048ffae227593a6363ee8.pdf.
蔡厚荣,张湘燕,李惠萍.实用间质性肺疾病[M].北京:人民卫生出版社,2016: 81-90.
国家技术监督局.中医临床诊疗术语:证候部分 GB/T16751.2-1997[S].北京:中国标准出版社,1997.
李灿东.中医诊断学[M].北京:中国中医药出版社,2016: 127-189.
陈瑞,罗亚萍,徐勋华,等.武汉地区52例新型冠状病毒肺炎中医证治初探及典型病案分析[J].中医杂志,2020,61(9):741-744.
张侠,李柳,戴广川,等.南京地区42例新型冠状病毒肺炎临床特征及中医证候初探[J].南京中医药大学学报,2020,36(2):145-148.
郑文科,张俊华,杨丰文,等.从湿毒疫论治新型冠状病毒肺炎[J].中医杂志,2020,61(12):1024-1028.
黄云鉴,龚婕宁.论肺痹肺痿与肺纤维化的证治规律[J].时珍国医国药,2016,27(6):1439-1441.
王玉光.三年以来新型冠状病毒感染中医证治研究回顾与反思[J].北京中医药, 2023, 42(1):2-6.
温成平,谢志军.激素不同使用阶段的中医证候诊断和治疗指南[J].中华中医药杂志,2020,35(9):4536-4540.
刘清泉,齐文升,陈腾飞,等.北京市新型冠状病毒肺炎重型、危重型中医诊疗专家共识[J].北京中医药, 2023, 42(1):47-50.
0
浏览量
113
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构